knowledge -WSS

knowledge

author：entertainment 2025-09-06 01:59:46 - browse：68377

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： A look at other Americans who have crossed into North Korea over the years

hotspot

Wikipedia

WSS

A strong 6.5

Military medical care influenced by rank and race, new study finds

With measles on the rise, a personal story of a devastating disease

Readers respond to H5N1 and livestock movements, and more

A Theranos scientist

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

In age of alternative facts, a scholarly course on calling out crap

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Malaria cases in Florida and Texas: Here’s what you need to know

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Walensky prepares to leave CDC — and Congress — behind

Addiction experts warn against a second 'war on drugs'

As demand for Covid shots wanes, Moderna seeks its next success

Case highlights the risks of experimental stem cell therapy

Wildfire smoke exposes gaps in outdoor worker protections

Cytokinetics CEO stresses company can launch heart drug on its own

explore

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Anxious about a speech? A startup wants you to pop a minty cardiac drug

ER docs worry over extreme heat as a 'mass casualty event'

A strong 6.5

Readers respond to H5N1 and livestock movements, and more

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

hotspot

knowledge

Wikipedia

leisure time